UCLA Health and the UCLA Jonsson Comprehensive Cancer Center consistently recognized for patient care and research by U.S. News & World Report

Dr. Antoni Ribas has been named the 2020 honoree of the European Society for Medical Oncology Award for Translational Research.

Insightful guest speakers and experts in the field bring the future of cancer research to you

Drug combination is the first FDA-approved immunotherapy regimen to be used as a first-line therapy for liver cancer